Auven Therapeutics Leads $80m ADC Therapeutics Financing

Auven Therapeutics today announced that it has led portfolio company ADC Therapeutics’ $80 million private equity placement. Existing investor AstraZeneca participated in the placement alongside Auven Therapeutics and a top-tier group of new European and US-based investors.

Read the full press release